Surfactant Protein D as a Biomarker in COPD
Author Information
Author(s): Sin Don D, Leung Rochelle, Gan Wen Q, Man SF Paul
Primary Institution: The University of British Columbia
Hypothesis
Are circulating surfactant protein D (SPD) or Clara Cell protein-16 (CC16) levels associated with lung function or health status in patients with severe COPD?
Conclusion
Changes in serum SPD levels tracked well with changes in health status over a 3 month period in patients with severe COPD.
Supporting Evidence
- At baseline, FEV1 was inversely associated with serum SPD levels (P = 0.045).
- Changes in SPD levels correlated significantly with changes in CRQ scores (adjusted P = 0.008).
- The association was particularly notable between circulating SPD level and the dyspnea domain of the CRQ score (P = 0.018).
Takeaway
This study looked at a protein in the blood called surfactant protein D to see if it can help doctors understand how sick people with lung problems are. They found that changes in this protein can show how a person's health is getting better or worse.
Methodology
The study involved 23 patients with advanced COPD, measuring lung function, health status, and serum levels of SPD, CC16, and CRP at baseline and after 3 months.
Potential Biases
Potential for type I and type II errors due to small sample size and multiple statistical comparisons.
Limitations
The sample size was small, limiting the generalizability of the findings, and the study only included patients with severe COPD.
Participant Demographics
23 participants, 11 men and 12 women, average age 65 years.
Statistical Information
P-Value
0.045
Confidence Interval
49.2–128.7 ng/mL for SPD
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website